Abstract
The regulations in different countries on the toxicological testing of antimicrobial agents are similar and harmonized on an international basis. Existing requirements cover both the standard investigations performed with any other new class of therapeutic drug and investigations necessary due to the specific features of anti-infective agents. Such features are the therapeutic target (the microorganisms), the need to provide adequate treatment of patients even during clinical trials, and the potential of the drug to induce certain adverse reactions. The combination of toxicity tests used will be determined by the drug, its class and current knowledge.
Similar content being viewed by others
References
Commission of the European Communities: Notice to applicants. In: The rules governing medicinal products in the European Community. Volume 2. Brussels, 1989, p. 1–175.
Japanese Ministry of Health and Welfare: Notification No. 1–24 of the Pharmaceuticals Affairs Bureau (September 11, 1989). Tokyo, 1989.
Nordic Council on Medicine: Clinical trials of drugs. Nordic Guidelines. NLN Publication No. 11. Nordiska Läkemedelsnämnden, Uppsala, 1983.
US Food and Drug Administration: New drug, antibiotic and biologic drug product regulations. Final rule. 21 CFR Parts 312, 314, 511, and 514. Federal Register March 19, 1987, Vol. 52, No. 53.
US Food and Drug Administration and the Infectious Disease Society of America: General guidelines for the clinical evaluation of antiinfective drugs. Washington, DC, 1990.
Commission of the European Communities: Single dose toxicity. Note for guidance (March 16, 1987). Official Journal of the European Communities 1987, 30: 2–3.
Commission of the European Communities: Repeated dose toxicity. Note for guidance (November 28, 1983). Official Journal of the European Communities 1983, 26: 12–17.
Commission of the European Communities: Local tolerance testing of medicinial products. Note for guidance (Draft of February 1990). CEC III/3979/88-En. Brussels, 1990.
Zbinden G, Gross F (ed): Pharmacological methods in toxicology. Pergamon Press, Oxford, 1979.
Commission of the European Communities: Reproduction studies. Note for guidance (November 28, 1983). Official Journal of the European Communities 1983, 26: 20–22.
Commission of the European Communities: Testing of medicinal products for their mutagenic potential. Note for guidance (March 16, 1987). Official Journal of the European Comunities, 1987, 30: 4–6.
Commission of the European Communities: Carcinogenic potential. Note for guidance (November 28, 1983). Official Journal of the European Communities, 1983, 26: 23–28.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bass, R., Lehnert, T. Basic requirements for the toxicity testing of antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 9, 488–491 (1990). https://doi.org/10.1007/BF01964288
Issue Date:
DOI: https://doi.org/10.1007/BF01964288